For all patients, ischemic markers such as heart-type fatty-acid-binding protein (H-FABP) levels returned to normal at follow-up, while and troponin levels were significantly decreased (44,458 ng/L overall), particularly in CKD patients regardless of T2DM status (73,294 to 82,500 ng/L) [77]. The gene discussed is FABP3; the disease is chronic kidney disease.